Sterile Compounding
Reimagined for Clinical Precision
Sterixia is a developing a 503B outsourcing facility focused on sterile injectables and peptide-based therapies.
We partner with clinics and healthcare providers to ensure reliable access to high-quality compounded products—crafted with precision, compliance, and innovation at every step.
About Sterixia
Advancing Health Through Innovation and Integrity
Founded with the mission to raise the standard for compounded pharmaceuticals, Sterixia is building a state-of-the-art 503B facility designed around quality, automation, and trust.
From raw material sourcing to sterile manufacturing, every process is guided by FDA 503B compliance and Good Manufacturing Practices (cGMP). Our goal: to deliver consistent, safe, and effective injectables that empower clinicians and enhance patient outcomes
Sterixia Focus
Building a Robust Supply Chain to Support Clinics
Peptides & Hormone Therapies – Precision compounding for wellness and performance medicine.
Hospital & Clinic Injectables – Ready-to-use sterile injectables addressing ongoing shortage needs.
Anesthetics & Pain Management – Reliable formulations for surgical and procedural settings.
Customized Clinical Support – Partner-driven formulation development and batch planning.
Partner with us
Building the Future of Compounding, Together
Sterixia is currently engaging a select group of clinics and providers ahead of our first production runs.
If your practice is seeking a trusted 503B partner for consistent access, quality assurance, and innovation—let’s connect.